Últimas noticias sobre Portage Biotech (NASDAQ:PRTG) Bolsa

Portage Biotech

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Earnings

News

Markets

Trading Ideas

APDN

AUID

CERO

COMM

CRVS

EFSH

FSBW

NIVF

NUKK

PRTG

PRZO

PTPI

RZLV

SHLT

SSBK

TNXP

VSTE

Acciones de Corvus suben un 22,5% pre-market tras anunciar datos de Soquelitinib. Descubre más ganadores y perdedores.

Acciones de Corvus Pharmaceuticals (CRVS) suben alrededor del 22%; 20 acciones que se mueven en premercado

Portage Biotech Inc

<ul>
<li>Six of the top policy groups representing the U.S. automotive industry sent a letter to Trump administration officials, asking them to reconsider the 25% tariffs on auto parts</li>
<li>The letter says that many auto suppliers in the U.S.  are already "in distress," and that the tariffs could put the entire industry in jeopardy</li>
<li>Trump has said that he is looking for ways to help "some of the car companies," although what form that assistance may take is still unclear</li>
</ul>
<p>Six of the top policy groups representing the U.S. automotive industry sent a letter to officials in the Trump administration urging them to reconsider tariffs on the industry on Tuesday.</p>
<p>Earlier this month, President <strong>Donald Trump</strong> announced 25% tariffs on auto parts. The levies are set to take effect on Saturday, although there has been discussion of exemptions.&nbsp;</p>
<p>In the letter, the groups say that many auto suppliers who are already "in distress" won't be able to afford the additional cost increases. If the tariffs go forward as planned, experts warn that automotive production in the country would be in jeopardy.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>with $1,000 you can invest at just $0.26/share!</strong></a></strong></li>
<li><strong>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"><strong> </strong><strong>Tax deferring is their number one strategy</strong></a>.</strong></li>
</ul>
<p>The letter, which is addressed to Treasury Secretary <strong>Scott Bessent</strong>, Commerce Secretary <strong>Howard Lutnick</strong> and U.S. Trade Representative <strong>Jamieson Greer</strong>, reads, in part, according to Reuters, "Most auto suppliers are not capitalized for an abrupt tariff induced disruption. Many are already in distress and will face production stoppages, layoffs and bankruptcy. It only takes the failure of one supplier to lead to a shutdown of an automaker's production line. When this happens, as it did during the pandemic, all suppliers are impacted, and workers will lose their jobs."</p>
<p>The letter is signed by the heads of the Alliance for Automotive Innovation, American International Automobile Dealers Association, Autos Drive America, vehicle suppliers association MEMA, National Automobile Dealers Association, and American Automotive Policy Council. According to the groups, they represent the country's No. 1 manufacturing sector, and that the automotive industry provides 10 million jobs in all 50 states and contributes $1.2 trillion into the economy each year.&nbsp;</p>
<p><strong>Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks"><strong>One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</strong></a></strong></p>
<p>The groups seem to have hope that their pleas won't fall on deaf ears. "President Trump has indicated an openness to reconsidering the administration's 25% tariffs on imported automotive parts – similar to the tariff relief recently approved for consumer electronics and semiconductors. That would be a positive development and welcome relief," another section of the letter reads, according to <a href="https://www.cnbc.com/2025/04/22/auto-groups-lobby-trump-administration-against-parts-tariffs.html">CNBC</a>.&nbsp;</p>
<p><strong>Trump </strong>has previously talked about being willing to help some of the car companies as they work on moving production.</p>
<p>"I'm looking for something to help some of the car companies, where they're switching to parts that were made in Canada, Mexico and other places, and they need a little bit of time because they're going to make them here… But they need a little bit of time, so I'm talking about things like that,' <a href="https://www.youtube.com/watch?v=8yERLi7elEs">Trump told reporters</a> on April 14.</p>
<p>CNBC reports that the auto groups' letter concludes with, "We support more manufacturing and additional supply chains that run through the United States, but it is not possible to reroute global supply chains overnight or even in months. This will take time."</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel"><strong>invest pre-IPO from $0.60 per share now</strong></a></strong><strong>.</strong></li>
<li><strong><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></strong></li>
</ul>
<p><em><strong>Image: Shutterstock</strong></em></p>


Personal Finance

Auto Groups Unite To Lobby Against Trump, Say Many Suppliers Are Already 'In Distress'

<p>Subscription-based models have become more prevalent across a larger number of industries in recent years. In 2025, the global subscription e-commerce industry is projected to reach a value of<a href="https://www.precedenceresearch.com/subscription-e-commerce-market#:~:text=The%20global%20subscription%20e%2Dcommerce,9.36%25%20from%202025%20to%202034."> USD 20.58 billion</a>. It is anticipated to expand at a compound annual growth rate (CAGR) of 9.36% between 2025 and 2034. </p>
<p>Subscriptions are becoming popular among businesses of all kinds, from fitness applications to workplace solutions to coffee delivery services. This paradigm alters how firms function, expand, and attract significant investment, in addition to changing how consumers pay.</p>
<p>This post discusses the subscription-based business model, its types, advantages, and the factors making it so attractive for Venture Capital investors.</p>
<h2 class="wp-block-heading">Subscription-Based Models: How do they Work?&nbsp;</h2>
<p>A subscription model charges clients a regular fee for a product or service. The client picks how long and how frequently they want to get each offer. They can also cancel or renew their subscription any time.</p>
<p>Because there is no need for manual entry each cycle, costs are charged to the customer&#8217;s payment method, saving time and reducing errors.</p>
<p>Keeping existing subscribers is as crucial as gaining new ones. Effective marketing strategies for existing customers include tailored promotions, loyalty benefits, and regular updates on new features and benefits. The lasting relationship that a subscription model fosters between the company and its clients is what makes it valuable.</p>
<h2 class="wp-block-heading">Subscription-Based Model: Common Types</h2>
<h3 class="wp-block-heading">Box subscriptions</h3>
<p>With a <a href="https://www.benzinga.com/news/21/07/22110358/subscription-box-boom-how-solutions-provider-innovates-to-sustain-300-growth">box subscription</a>, you pay a set fee, usually monthly, to get a delivery full of handpicked items based on a theme. People like these boxes because they offer a bit of surprise and cater to specific interests. This keeps customers coming back. A popular example is IPSY&#8217;s BoxyCharm. When you sign up, you fill out a quick quiz to guide what goes in your box, which includes skincare and beauty products. Everything starts as soon as you decide how frequently you want the boxes and make the payment.</p>
<h3 class="wp-block-heading">SaaS Subscription</h3>
<p>Users of this model pay to access software on a subscription basis rather than buying it altogether. Because the provider takes care of all the upkeep and upgrades, they have access to software that is constantly current. Slack, Zoom, and Shopify are a few famous examples of SaaS-based subscription models.&nbsp;</p>
<p>To design and create scalable, cloud-native apps that support strong subscription logic, automated billing, user management, and analytics, many startups and businesses refer to companies providing <a href="https://solicy.net/software/saas-development-services">SaaS development services</a>. Adopting a subscription model is a strategic choice that affects product architecture, user onboarding, feature planning, and customer support for companies developing SaaS solutions. It goes beyond a simple price.&nbsp;</p>
<h3 class="wp-block-heading">Content subscription</h3>
<p>Assume you want to read a piece from The New York Times newspaper. You could be allowed to read a certain amount of articles for free each month, but you would have to pay to read as many as you like.</p>
<p>An excellent example of how a traditional newspaper modified its business strategy to become subscription-based and increase income is the New York Times.</p>
<h3 class="wp-block-heading">Usage-based subscription</h3>
<p>Any kind of bill (such as electricity) is a traditional example of this type of subscription &#8211; you only pay for the amount of services used. In the digital realm, this may be quantified through data transfers, storage space, and API requests. Usage-based subscriptions are very common in SaaS platforms and cloud services.&nbsp;</p>
<p>Typical examples include Google Cloud and AWS. This subscription type is chosen by businesses or individuals who prefer to pay only for what they use, not more.&nbsp;</p>
<h3 class="wp-block-heading">Membership subscription&nbsp;</h3>
<p>Do you visit your neighborhood gym? You&#8217;re a fan of Pilates? In the real world, these are membership subscriptions. Typically, these membership subscriptions in the digital realm include access to clubs, special materials, and more. A great example of this kind of subscription is Sephora Beauty Insider. Here, subscribers earn points with their purchases, get early access to sales, and are treated as VIP clients.&nbsp;</p>
<h3 class="wp-block-heading">Freemium subscriptions</h3>
<p>Companies charge for more sophisticated features while offering a basic service for free. This is common for software and online services, where the paid version unlocks all features while the free version could contain restrictions or ads. Zoom, for instance, provides both a free and a premium membership in which users may access more capabilities than those available in the free version.</p>
<h2 class="wp-block-heading">Benefits of Subscription-Based Models</h2>
<h3 class="wp-block-heading">Easy Scalability</h3>
<p>Businesses may develop their operations with no additional expense as client demand increases. Many subscription-based systems are built on an automated design that allows companies to efficiently serve more customers without significantly increasing their resource allocation</p>
<h3 class="wp-block-heading">More predictability</h3>
<ol start="2"></ol>
<p>Subscription-based business models provide company owners greater stability than traditional business models. This is because they already know how much money they will get at the end of the month. This aids them in making well-informed choices about resource allocation and budget planning. </p>
<h3 class="wp-block-heading">Better Customer Relationships</h3>
<ol start="3"></ol>
<p>With each subscription renewal or interaction, businesses may demonstrate their commitment to providing long-term value by implementing updates, new features, or enhancements. This continuous stream of updates and personalized services increases customer satisfaction and cultivates loyalty. Consumers feel they are getting a service that evolves and changes with them.</p>
<h2 class="wp-block-heading">Why VCs Love Subscription-Based Models</h2>
<p>Venture capital (VC) is the term for money given by investors to firms that are in their early stages or are expanding and have a lot of room to develop, but also carry a lot of risk. </p>
<p>The typical compensation for venture investors is equity, or ownership shares, in the business.</p>
<p>Nowadays, VCs have become very attracted to subscription-based models. In 2023, businesses with a SaaS business model received 47% of venture capital investments, continuing a trend that had been increasing over the previous ten years.</p>
<p>Here are a few reasons why VCs are particularly drawn to subscription-based businesses:</p>
<h3 class="wp-block-heading">High Margins</h3>
<p>SaaS subscription-based businesses frequently have margins higher than 70%. High margins show that a company is making money and controlling expenses effectively. Higher profit margins allow businesses to make larger investments in expansion, innovation, and client acquisition. Companies with strong profit margins are more resilient to changes in the market and downturns in the economy.</p>
<h3 class="wp-block-heading">Predictable Revenue</h3>
<p>Recurring income from a subscriber base helps you make more accurate predictions about how much money the company will make each quarter. This is particularly beneficial for the investors, since it adds one more level of trust and peace that their investment will be worthy.&nbsp;</p>
<h3 class="wp-block-heading">Retention of Customers</h3>
<p>The ability of a company to maintain current clients over time is known as customer retention. It indicates that you&#8217;re fostering customer loyalty and promoting recurring purchases, subscriptions, and interaction rather than merely drawing in new customers. </p>
<p>If customers continue to use your product, it indicates that it has genuine value. Your profit margins will be higher if you spend less on attracting and retaining clients. This goes back to the second point &#8211; predictable revenue, due to loyal clients.&nbsp;</p>
<h2 class="wp-block-heading">Top VCs investing in subscription-based models</h2>
<h3 class="wp-block-heading">Sequoia Capital</h3>
<p>With a portfolio of almost 2,000 businesses, Sequoia Capital has made investments in prestigious SaaS firms including Dropbox, Loom, Notion, HubSpot, Zoom, and Drift. The organization is renowned for providing capital to innovative companies in a variety of sectors, such as deep tech, energy, healthcare, and finance.</p>
<h2 class="wp-block-heading">General Catalyst Partners</h2>
<p>General Catalyst Partners is an American venture capital firm that has an outstanding history of supporting innovative businesses that have revolutionized whole sectors. Their primary focus was on early-stage companies, offering young startups money and advice. The effectiveness of this strategy allowed the firm to establish a strong presence in Silicon Valley by 2010, ensuring its position at the forefront of the digital revolution.</p>
<p>The astonishing assortment of businesses in General Catalyst&#8217;s investment portfolio includes Datto, Stripe, Airbnb, and many more.</p>
<h3 class="wp-block-heading">First Round Capital</h3>
<p>First Round Capital is venture capital firm established in 2004. With an emphasis on industries such as enterprise, fintech, healthcare, consumer goods, hardware, artificial intelligence, and web3, the business focuses on early-stage investments. Among the companies they have invested in are Notion, Clay, and Uber.</p>
<h2 class="wp-block-heading">Conclusion&nbsp;</h2>
<p>Venture capitalists are especially interested in them because of subscription-based business models offer a mix of consistent revenue, high customer lifetime value, and strong retention rates.</p>
<p>It is worth noting, nevertheless, that a subscription-based business model cannot be a great fit for all businesses. Finding a balance between what is and is not functioning is the key. Continue to improve your strategy, ask for feedback from customers, and stay updated to keep up with the trends.</p>


Opinion

General

Why Subscription-Based Models Are Attracting Major VC Investments

<p>Wells Fargo  analyst Finian O'Shea   maintains Morgan Stanley Direct (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSDL#NYSE">MSDL</a>) with a Equal-Weight and lowers the price target from $20 to $19.</p>


Price Target

Analyst Ratings

MSDL

Wells Fargo Maintains Equal-Weight on Morgan Stanley Direct, Lowers Price Target to $19

<p>Wells Fargo  analyst Finian O'Shea   maintains MidCap Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFIC#NASDAQ">MFIC</a>) with a Overweight and lowers the price target from $14 to $13.</p>


MFIC

Wells Fargo Maintains Overweight on MidCap Financial, Lowers Price Target to $13

<p>Wells Fargo  analyst Finian O'Shea   maintains Kayne Anderson BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBDC#NYSE">KBDC</a>) with a Overweight and lowers the price target from $17 to $16.</p>


KBDC

Wells Fargo Maintains Overweight on Kayne Anderson BDC, Lowers Price Target to $16

<p>Evercore ISI Group  analyst Durgesh Chopra   maintains FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) with a Outperform and raises the price target from $41 to $47.</p>


Evercore ISI Group Maintains Outperform on FirstEnergy, Raises Price Target to $47

<p>Wells Fargo  analyst Finian O'Shea   maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and lowers the price target from $21 to $19.</p>


HTGC

Wells Fargo Maintains Overweight on Hercules Capital, Lowers Price Target to $19

<p>Evercore ISI Group  analyst Duane Pfenningwerth   maintains Diamondrock Hospitality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>) with a In-Line and lowers the price target from $10 to $9.</p>


Evercore ISI Group Maintains In-Line on Diamondrock Hospitality, Lowers Price Target to $9

<p>Wells Fargo  analyst Finian O'Shea   maintains Golub Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBDC#NASDAQ">GBDC</a>) with a Equal-Weight and lowers the price target from $15 to $14.</p>


GBDC

Wells Fargo Maintains Equal-Weight on Golub Capital BDC, Lowers Price Target to $14

<p>Stephens &amp; Co.  analyst Russell Gunther   reiterates WSFS Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSFS#NASDAQ">WSFS</a>) with a Overweight and maintains $64 price target.</p>


Reiteration

WSFS

Stephens & Co. Reiterates Overweight on WSFS Financial, Maintains $64 Price Target

<p>Evercore ISI Group  analyst James Kammert   maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Outperform and lowers the price target from $23 to $21.</p>


Evercore ISI Group Maintains Outperform on Healthpeak Properties, Lowers Price Target to $21

<p>Wells Fargo  analyst Finian O'Shea   maintains Goldman Sachs BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSBD#NYSE">GSBD</a>) with a Underweight and lowers the price target from $12 to $10.</p>


GSBD

Wells Fargo Maintains Underweight on Goldman Sachs BDC, Lowers Price Target to $10

<p>Evercore ISI Group  analyst Amit Daryanani   maintains Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) with a Outperform and lowers the price target from $145 to $120.</p>


DELL

Evercore ISI Group Maintains Outperform on Dell Technologies, Lowers Price Target to $120

<p>Stephens &amp; Co.  analyst Andrew Terrell   reiterates TriCo Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBK#NASDAQ">TCBK</a>) with a Overweight and maintains $47 price target.</p>


TCBK

Stephens & Co. Reiterates Overweight on TriCo Bancshares, Maintains $47 Price Target

<p>Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Royal Caribbean Gr will report an <strong>earnings per share</strong> (EPS) of $2.53.</p>
<p>Investors in Royal Caribbean Gr are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.13, which was followed by a 1.45% increase in the share price the next day.</p>
<p>Here's a look at Royal Caribbean Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.50</td>
<td>5.03</td>
<td>2.75</td>
<td>1.33</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.63</td>
<td>5.20</td>
<td>3.21</td>
<td>1.77</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848957_0.png" alt="eps graph" /></p>
<h3>Tracking Royal Caribbean Gr's Stock Performance</h3>
<p>Shares of Royal Caribbean Gr were trading at $211.97 as of April 25. Over the last 52-week period, shares are up 56.02%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/RCL/earnings"><strong>To track all earnings releases for Royal Caribbean Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights Ahead: Royal Caribbean Gr's Quarterly Earnings

<p>Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Novartis to report an <strong>earnings per share</strong> (EPS) of $2.08.</p>
<p>The market awaits Novartis's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.19 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p>
<p>Here's a look at Novartis's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.79</td>
<td>1.96</td>
<td>1.86</td>
<td>1.69</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.98</td>
<td>2.06</td>
<td>1.97</td>
<td>1.80</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848950_0.png" alt="eps graph" /></p>
<h3>Novartis Share Price Analysis</h3>
<p>Shares of Novartis were trading at $112.14 as of April 25. Over the last 52-week period, shares are up 15.69%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/NVS/earnings"><strong>To track all earnings releases for Novartis visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For Novartis

<p>BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that BP will report an <strong>earnings per share</strong> (EPS) of $0.69.</p>
<p>The market awaits BP's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company missed EPS by $0.01, which was followed by a 0.38% increase in the share price the next day.</p>
<p>Here's a look at BP's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.45</td>
<td>0.76</td>
<td>0.92</td>
<td>1</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.44</td>
<td>0.83</td>
<td>1</td>
<td>0.97</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848942_0.png" alt="eps graph" /></p>
<h3>BP Share Price Analysis</h3>
<p>Shares of BP were trading at $29.19 as of April 25. Over the last 52-week period, shares are down 24.63%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/BP/earnings"><strong>To track all earnings releases for BP visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For BP

<p>Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Hilton Worldwide Holdings will report an <strong>earnings per share</strong> (EPS) of $1.62.</p>
<p>The announcement from Hilton Worldwide Holdings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.08, which was followed by a 0.26% drop in the share price the next day.</p>
<p>Here's a look at Hilton Worldwide Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.68</td>
<td>1.85</td>
<td>1.85</td>
<td>1.42</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.76</td>
<td>1.92</td>
<td>1.91</td>
<td>1.53</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>1.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848931_0.png" alt="eps graph" /></p>
<h3>Hilton Worldwide Holdings Share Price Analysis</h3>
<p>Shares of Hilton Worldwide Holdings were trading at $219.62 as of April 25. Over the last 52-week period, shares are up 13.44%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/HLT/earnings"><strong>To track all earnings releases for Hilton Worldwide Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Hilton Worldwide Holdings's Earnings Preview

<p>Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Sherwin-Williams to report an <strong>earnings per share</strong> (EPS) of $2.18.</p>
<p>Anticipation surrounds Sherwin-Williams's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.03, which was followed by a 2.02% drop in the share price the next day.</p>
<p>Here's a look at Sherwin-Williams's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.06</td>
<td>3.54</td>
<td>3.48</td>
<td>2.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.09</td>
<td>3.37</td>
<td>3.70</td>
<td>2.17</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>0.0%</td>
<td>-4.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848922_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Sherwin-Williams were trading at $331.62 as of April 25. Over the last 52-week period, shares are up 11.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Sherwin-Williams</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Sherwin-Williams.</p>
<p>Analysts have provided Sherwin-Williams with 11 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $387.09, suggesting a potential 16.73% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Ecolab, DuPont de Nemours and PPG Indus, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Ecolab, with an average 1-year price target of $285.71, suggesting a potential 13.84% downside.</li>
<li>Analysts currently favor an Outperform trajectory for DuPont de Nemours, with an average 1-year price target of $87.38, suggesting a potential 73.65% downside.</li>
<li>Analysts currently favor an Neutral trajectory for PPG Indus, with an average 1-year price target of $125.45, suggesting a potential 62.17% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Ecolab, DuPont de Nemours and PPG Indus, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sherwin-Williams</td>
<td>Neutral</td>
<td>0.86%</td>
<td>$2.57B</td>
<td>11.70%</td>
</tr>
<tr>
<td>Ecolab</td>
<td>Outperform</td>
<td>1.70%</td>
<td>$1.74B</td>
<td>5.47%</td>
</tr>
<tr>
<td>DuPont de Nemours</td>
<td>Outperform</td>
<td>6.69%</td>
<td>$1.12B</td>
<td>-0.50%</td>
</tr>
<tr>
<td>PPG Indus</td>
<td>Neutral</td>
<td>-7.72%</td>
<td>$755M</td>
<td>-3.84%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Sherwin-Williams ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks lower for Return on Equity. Overall, Sherwin-Williams is positioned favorably compared to its peers in terms of financial performance metrics.</p>
<h3>About Sherwin-Williams</h3>
<p>Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.</p>
<h3>Financial Insights: Sherwin-Williams</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Sherwin-Williams's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>0.86%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Sherwin-Williams's net margin is impressive, surpassing industry averages. With a net margin of <strong>9.06%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Sherwin-Williams's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>11.7%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Sherwin-Williams's ROA excels beyond industry benchmarks, reaching <strong>2.02%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>2.94</strong>, Sherwin-Williams faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/SHW/earnings"><strong>To track all earnings releases for Sherwin-Williams visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Sherwin-Williams's Upcoming Earnings

<p>Wells Fargo  analyst Finian O'Shea   maintains FS KKR Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>) with a Underweight and lowers the price target from $19 to $18.</p>


Wells Fargo Maintains Underweight on FS KKR Capital, Lowers Price Target to $18

Press Releases

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

Management

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

Financing

Portage Biotech Announces Completion of $2.15 Million Private Financing

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Health Care

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Emerging Tech Quartet – PRSO, LXRX, PRTG, RNAZ – Drive Breakthroughs Across Defense, Obesity, Oncology, and RNA Therapeutics

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

LXRX

PRSO

RNAZ

ABVC BioPharma

BioVie

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Equillium

Ernexa Therapeutics

Evaxion Biotech A/S - American Depositary Share

Evaxion Biotech

Geovax Labs

Imunon

IN8bio

Kairos Pharma

Moleculin Biotech

MEI Pharma

Marker Therapeutics

Minerva Neurosciences, Inc - Common Stock

Comments

Portage Biotech

Noticias

Últimas noticias sobre Portage Biotech (NASDAQ:PRTG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL